X0306
4
2019-12-31
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001190644
INGRAM DOUGLAS S
215 FIRST STREET, SUITE 415
CAMBRIDGE
MA
02142
1
1
0
0
President & CEO
Common Stock
2019-12-31
4
F
0
37185
129.04
D
395012
D
Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.
/s/ David Tyronne Howton, as Attorney-in-Fact for Douglas S. Ingram
2020-01-03